Skip to main content
SUSMED, Inc. logo

SUSMED, Inc. — Investor Relations & Filings

Ticker · 4263 ISIN · JP3319150003 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 33 across all filing types
Latest filing 2025-09-26 Audit Report / Informat…
Country JP Japan
Listing T 4263

About SUSMED, Inc.

https://www.susmed.co.jp/

SUSMED, Inc. is a research and development-oriented company that promotes digital medicine. The company's business is centered on two main areas: the development of digital therapeutics (DTx), or therapeutic applications, for various diseases such as insomnia, and the provision of clinical development support systems. These systems, which may utilize technologies like blockchain for data management, are designed to improve the efficiency of clinical trials for pharmaceutical development. The company operates under the concept of creating "sustainable medicine" through its technological solutions.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. This specific document is a mandatory attachment to an Annual Securities Report (Yukashoken Hokokusho), where the CEO confirms the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'RPA' or '10-K', it falls under the 'RNS' (Regulatory Filings) category as a miscellaneous regulatory disclosure. FY 2025
2025-09-26 Japanese
有価証券報告書－第10期(2024/07/01－2025/06/30)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, business overview, and management information for the fiscal year ending June 30, 2025. The document structure, including the header with filing date, fiscal period, and company information, confirms it is the official annual filing. FY 2025
2025-09-26 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO of SUSMED, Inc. regarding the accuracy of the interim report for the period ending December 31, 2024. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). H1 10
2025-02-14 Japanese
半期報告書－第10期(2024/07/01－2025/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by SUSMED, Inc. with the Kanto Local Finance Bureau on February 14, 2025. It covers the interim accounting period from July 1, 2024, to December 31, 2024. It contains detailed financial statements, management analysis (MD&A), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-02-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and explicitly states its purpose in Section 1: '当社は、2024年９月27日開催の第９期定時株主総会において、決議事項が決議されましたので...本報告書を提出するものであります。' (Our company is submitting this report based on the resolutions passed at the 9th Annual General Meeting held on September 27, 2024). The content details the resolutions passed (e.g., changes to articles of incorporation, election of directors, approval of remuneration) and the voting results. This structure—reporting the outcomes of an Annual General Meeting (AGM)—fits the definition of AGM Information (AGM-R). Although it relates to an AGM, the document itself is the official report of the results, not just a presentation (AGM-R) or a proxy solicitation (PSI). Since it reports the definitive results of the AGM, AGM-R is the most precise fit, although RNS (Regulatory Filing) is also plausible as it is a formal filing reporting meeting outcomes. Given the specific content detailing the resolutions and voting tallies of the AGM, AGM-R is selected.
2024-09-27 Japanese
内部統制報告書－第9期(2023/07/01－2024/06/30)
Governance Information Classification · 100% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項). The content discusses the framework, scope, procedures, and conclusion regarding the assessment of internal controls over financial reporting, referencing the assessment date (June 30, 2024) and concluding that internal controls are effective. This structure is characteristic of a formal internal control report filed under Japanese regulations, which is analogous to the Sarbanes-Oxley Section 404 reporting requirements in the US context. Among the provided codes, 'AR' (Audit Report / Information) is the closest fit for a formal, standalone report detailing internal control effectiveness and audit-related principles, although 'AR' is defined broadly. Given the specific nature of an Internal Control Report, which is a mandatory regulatory filing focused on financial reporting integrity, and lacking a specific code for 'Internal Control Report', 'AR' is the most appropriate classification as it covers standalone audit/regulatory assurance reports.
2024-09-27 Japanese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.